EpiSwitchTM
- Oxford BioDynamics has created and produced a novel and revolutionary diagnostic technology called the EpiSwitchTM for the reliable, sensitive, specific and early detection of aberrant gene expression.
- The EpiSwitchTM technology offers a highly affordable means of non-invasive screening; early detection; monitoring and prognosis of major diseases associated with aberrant gene expression including cancer, inflammatory, cardiovascular, and neurodegenerative conditions.
- The technology provides early detection of aberrant gene expression in very low copy numbers and in a small sample of abnormal cells, literally finding a needle in a hay stack at the early stage of the disease.
- The EpiSwitchTM test can be non invasive and produces results in a few hours